Skip to main content

SOBI · Swedish Orphan Biovitrum AB (publ) · Financials

428.6000 SEK +3.8000 (+0.89%) At close · Oct 6
Market Cap
152.10B SEK
Shares
348.70M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
26.03B +17.6%
FY2024 Revenue FY2020–FY2024
Net Income
3.89B +61.3%
FY2024 Net Income FY2020–FY2024
Gross Margin
77.77% +0.4pp
FY2024 Gross Margin FY2020–FY2024
Operating Margin
21.61% +3.2pp
FY2024 Operating Margin FY2020–FY2024
Operating Cash Flow
7.39B +65.3%
FY2024 Operating Cash Flow FY2020–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2024 FY2023 FY2022 FY2021 FY2020
SEK 26.03B 22.12B 18.79B 15.53B 15.26B
SEK 5.79B 5B 4.78B 3.48B 3.23B
SEK 20.24B 17.13B 14.01B 12.05B 12.04B
SEK 3.54B 2.8B 2.35B 1.99B 1.59B
SEK 5.63B 4.07B 3.81B 3.73B 4.82B
SEK 1.31B 1.16B 497M 454M 602M
SEK 4.41B 2.95B 3.32B 3.3B 4.22B
SEK 528M 546M 683M 616M 972M
SEK 3.89B 2.41B 2.64B 2.68B 3.25B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current borrowings, including current portion of noncurrent borrowings 2024-12-31 SEK 3,926,000,000 ESEF Annual Report filed 2025-05-08
Current lease liabilities 2024-12-31 SEK 134,000,000 ESEF Annual Report filed 2025-05-08
Noncurrent lease liabilities 2024-12-31 SEK 268,000,000 ESEF Annual Report filed 2025-05-08
Noncurrent long-term borrowings 2024-12-31 SEK 12,407,000,000 ESEF Annual Report filed 2025-05-08
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.